LAZERTINIB for Egfr gene mutation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where LAZERTINIB was used for Egfr gene mutation.
Most Reported Side Effects for LAZERTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 77 | 21.9% | 0 | 3 |
| Neuropathy peripheral | 32 | 9.1% | 0 | 0 |
| Infusion related reaction | 30 | 8.5% | 1 | 6 |
| Fatigue | 26 | 7.4% | 2 | 4 |
| Diarrhoea | 20 | 5.7% | 0 | 4 |
| Off label use | 19 | 5.4% | 0 | 5 |
| Paronychia | 16 | 4.6% | 0 | 1 |
| Pruritus | 13 | 3.7% | 0 | 0 |
| Nausea | 12 | 3.4% | 1 | 2 |
| Dyspnoea | 11 | 3.1% | 1 | 2 |
| Oedema peripheral | 11 | 3.1% | 0 | 4 |
| Hypoaesthesia | 10 | 2.8% | 0 | 1 |
| Stomatitis | 10 | 2.8% | 0 | 1 |
| Decreased appetite | 9 | 2.6% | 0 | 0 |
| Non-small cell lung cancer | 9 | 2.6% | 1 | 1 |
Other Indications for LAZERTINIB
Non-small cell lung cancer (133)
Product used for unknown indication (114)
Lung neoplasm malignant (44)
Non-small cell lung cancer metastatic (16)
Lung adenocarcinoma stage iv (6)
Lung carcinoma cell type unspecified recurrent (5)
Other Drugs Used for Egfr gene mutation
AFATINIB (780)
OSIMERTINIB (695)
GEFITINIB (97)
AMIVANTAMAB-VMJW (89)
ERLOTINIB (52)
PEMETREXED (34)
CARBOPLATIN (30)
MOBOCERTINIB (26)
BEVACIZUMAB (25)
NINTEDANIB (24)